Structure

Physi-Chem Properties

Molecular Weight:  296.16
Volume:  304.221
LogP:  1.671
LogD:  1.451
LogS:  -2.983
# Rotatable Bonds:  2
TPSA:  90.15
# H-Bond Aceptor:  5
# H-Bond Donor:  4
# Rings:  2
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.648
Synthetic Accessibility Score:  4.197
Fsp3:  0.625
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.737
MDCK Permeability:  7.455390004906803e-06
Pgp-inhibitor:  0.001
Pgp-substrate:  0.322
Human Intestinal Absorption (HIA):  0.037
20% Bioavailability (F20%):  0.852
30% Bioavailability (F30%):  0.39

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.99
Plasma Protein Binding (PPB):  66.41826629638672%
Volume Distribution (VD):  1.473
Pgp-substrate:  25.247447967529297%

ADMET: Metabolism

CYP1A2-inhibitor:  0.032
CYP1A2-substrate:  0.264
CYP2C19-inhibitor:  0.015
CYP2C19-substrate:  0.862
CYP2C9-inhibitor:  0.006
CYP2C9-substrate:  0.374
CYP2D6-inhibitor:  0.006
CYP2D6-substrate:  0.376
CYP3A4-inhibitor:  0.011
CYP3A4-substrate:  0.323

ADMET: Excretion

Clearance (CL):  5.111
Half-life (T1/2):  0.358

ADMET: Toxicity

hERG Blockers:  0.032
Human Hepatotoxicity (H-HT):  0.108
Drug-inuced Liver Injury (DILI):  0.169
AMES Toxicity:  0.033
Rat Oral Acute Toxicity:  0.07
Maximum Recommended Daily Dose:  0.018
Skin Sensitization:  0.021
Carcinogencity:  0.013
Eye Corrosion:  0.003
Eye Irritation:  0.012
Respiratory Toxicity:  0.013

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470727

Natural Product ID:  NPC470727
Common Name*:   (1R)-7-Methoxy-1,6-Dimethyl-4-Propan-2-Yl-2,3-Dihydronaphthalene-1,2,3,4-Tetrol
IUPAC Name:   (1R)-7-methoxy-1,6-dimethyl-4-propan-2-yl-2,3-dihydronaphthalene-1,2,3,4-tetrol
Synonyms:  
Standard InCHIKey:  ZVZHQJHYUIHXPZ-MYLOQMAZSA-N
Standard InCHI:  InChI=1S/C16H24O5/c1-8(2)16(20)11-6-9(3)12(21-5)7-10(11)15(4,19)13(17)14(16)18/h6-8,13-14,17-20H,1-5H3/t13?,14?,15-,16?/m1/s1
SMILES:  COc1cc2c(cc1C)C(O)(C(C)C)C(C([C@]2(C)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2206803
PubChem CID:   71459705
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001550] Sesquiterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32770 sterculia tavia Species Malvaceae Eukaryota n.a. Madagascar Rain Forest n.a. PMID[23149304]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT179 Cell Line A2780 Homo sapiens IC50 = 35500.0 nM PMID[468031]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470727 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9675 High Similarity NPC470724
0.9435 High Similarity NPC470726
0.8947 High Similarity NPC472800
0.8947 High Similarity NPC327735
0.8939 High Similarity NPC16485
0.8806 High Similarity NPC68292
0.8806 High Similarity NPC126101
0.8797 High Similarity NPC311256
0.8705 High Similarity NPC221318
0.8692 High Similarity NPC186889
0.8692 High Similarity NPC471077
0.8686 High Similarity NPC265075
0.8682 High Similarity NPC4286
0.8682 High Similarity NPC105031
0.8682 High Similarity NPC76119
0.8682 High Similarity NPC293801
0.8676 High Similarity NPC6300
0.8676 High Similarity NPC114171
0.8676 High Similarity NPC184613
0.8676 High Similarity NPC230124
0.8647 High Similarity NPC18842
0.8636 High Similarity NPC196193
0.8636 High Similarity NPC143483
0.8626 High Similarity NPC472968
0.8615 High Similarity NPC82299
0.8603 High Similarity NPC3072
0.8603 High Similarity NPC46277
0.8603 High Similarity NPC156948
0.8603 High Similarity NPC301765
0.8603 High Similarity NPC86605
0.8594 High Similarity NPC152946
0.8593 High Similarity NPC256262
0.8583 High Similarity NPC129176
0.8582 High Similarity NPC26394
0.8582 High Similarity NPC474397
0.8582 High Similarity NPC227719
0.8571 High Similarity NPC15543
0.8571 High Similarity NPC312341
0.8571 High Similarity NPC472457
0.8561 High Similarity NPC472797
0.8561 High Similarity NPC258083
0.855 High Similarity NPC118533
0.855 High Similarity NPC5428
0.855 High Similarity NPC473221
0.855 High Similarity NPC165045
0.855 High Similarity NPC469386
0.854 High Similarity NPC32630
0.8531 High Similarity NPC158784
0.8529 High Similarity NPC263367
0.8529 High Similarity NPC54743
0.8529 High Similarity NPC10737
0.8529 High Similarity NPC133025
0.8529 High Similarity NPC477939
0.8529 High Similarity NPC177160
0.8529 High Similarity NPC209985
0.8529 High Similarity NPC29799
0.8529 High Similarity NPC156502
0.8527 High Similarity NPC474160
0.8519 High Similarity NPC209199
0.8511 High Similarity NPC233980
0.8507 High Similarity NPC228843
0.8507 High Similarity NPC230219
0.8507 High Similarity NPC59239
0.8507 High Similarity NPC472798
0.85 High Similarity NPC473845
0.8496 Intermediate Similarity NPC11089
0.8489 Intermediate Similarity NPC175838
0.8489 Intermediate Similarity NPC186033
0.8489 Intermediate Similarity NPC470917
0.8485 Intermediate Similarity NPC470084
0.8478 Intermediate Similarity NPC12668
0.8478 Intermediate Similarity NPC308768
0.8472 Intermediate Similarity NPC2745
0.8472 Intermediate Similarity NPC302915
0.8467 Intermediate Similarity NPC477938
0.8467 Intermediate Similarity NPC56329
0.8467 Intermediate Similarity NPC266006
0.8467 Intermediate Similarity NPC242715
0.8467 Intermediate Similarity NPC22902
0.8456 Intermediate Similarity NPC180602
0.8456 Intermediate Similarity NPC240279
0.8456 Intermediate Similarity NPC55239
0.8456 Intermediate Similarity NPC214853
0.8456 Intermediate Similarity NPC313081
0.845 Intermediate Similarity NPC77789
0.845 Intermediate Similarity NPC57199
0.845 Intermediate Similarity NPC18128
0.844 Intermediate Similarity NPC90645
0.8433 Intermediate Similarity NPC277804
0.8433 Intermediate Similarity NPC78575
0.8433 Intermediate Similarity NPC160623
0.8433 Intermediate Similarity NPC474017
0.8429 Intermediate Similarity NPC477616
0.8421 Intermediate Similarity NPC472795
0.8421 Intermediate Similarity NPC472796
0.8417 Intermediate Similarity NPC71046
0.8417 Intermediate Similarity NPC87725
0.8417 Intermediate Similarity NPC263261
0.8414 Intermediate Similarity NPC160196
0.8414 Intermediate Similarity NPC157783
0.8414 Intermediate Similarity NPC325860
0.8409 Intermediate Similarity NPC242032
0.8409 Intermediate Similarity NPC21563
0.8406 Intermediate Similarity NPC132804
0.8406 Intermediate Similarity NPC220344
0.8406 Intermediate Similarity NPC243759
0.8406 Intermediate Similarity NPC471183
0.8406 Intermediate Similarity NPC79622
0.8406 Intermediate Similarity NPC212942
0.8406 Intermediate Similarity NPC243996
0.8406 Intermediate Similarity NPC29868
0.8406 Intermediate Similarity NPC275061
0.8406 Intermediate Similarity NPC105847
0.8406 Intermediate Similarity NPC218131
0.8403 Intermediate Similarity NPC195561
0.8397 Intermediate Similarity NPC124030
0.8397 Intermediate Similarity NPC81641
0.8397 Intermediate Similarity NPC148627
0.8394 Intermediate Similarity NPC470802
0.8394 Intermediate Similarity NPC143139
0.8394 Intermediate Similarity NPC234952
0.8394 Intermediate Similarity NPC205442
0.8394 Intermediate Similarity NPC30632
0.8394 Intermediate Similarity NPC202846
0.8392 Intermediate Similarity NPC212142
0.8382 Intermediate Similarity NPC206737
0.8382 Intermediate Similarity NPC56764
0.8382 Intermediate Similarity NPC125649
0.8382 Intermediate Similarity NPC276026
0.8382 Intermediate Similarity NPC188378
0.8382 Intermediate Similarity NPC555
0.8382 Intermediate Similarity NPC469659
0.8382 Intermediate Similarity NPC471942
0.8382 Intermediate Similarity NPC7515
0.8382 Intermediate Similarity NPC473107
0.8382 Intermediate Similarity NPC289258
0.8382 Intermediate Similarity NPC187616
0.8382 Intermediate Similarity NPC49603
0.8382 Intermediate Similarity NPC193026
0.838 Intermediate Similarity NPC471608
0.838 Intermediate Similarity NPC274454
0.838 Intermediate Similarity NPC112251
0.838 Intermediate Similarity NPC215678
0.8372 Intermediate Similarity NPC476633
0.837 Intermediate Similarity NPC14224
0.837 Intermediate Similarity NPC102256
0.837 Intermediate Similarity NPC161958
0.837 Intermediate Similarity NPC6451
0.8369 Intermediate Similarity NPC50250
0.8369 Intermediate Similarity NPC164183
0.8369 Intermediate Similarity NPC473108
0.8369 Intermediate Similarity NPC469795
0.8358 Intermediate Similarity NPC42300
0.8358 Intermediate Similarity NPC241522
0.8358 Intermediate Similarity NPC242807
0.8358 Intermediate Similarity NPC92164
0.8358 Intermediate Similarity NPC192687
0.8358 Intermediate Similarity NPC145305
0.8358 Intermediate Similarity NPC174495
0.8358 Intermediate Similarity NPC99795
0.8358 Intermediate Similarity NPC224157
0.8358 Intermediate Similarity NPC187998
0.8358 Intermediate Similarity NPC64201
0.8358 Intermediate Similarity NPC77040
0.8358 Intermediate Similarity NPC153739
0.8358 Intermediate Similarity NPC126836
0.8358 Intermediate Similarity NPC257582
0.8346 Intermediate Similarity NPC38604
0.8346 Intermediate Similarity NPC215300
0.8346 Intermediate Similarity NPC211179
0.8346 Intermediate Similarity NPC307050
0.8346 Intermediate Similarity NPC28765
0.8346 Intermediate Similarity NPC38017
0.8346 Intermediate Similarity NPC277458
0.8346 Intermediate Similarity NPC223912
0.8345 Intermediate Similarity NPC34431
0.8345 Intermediate Similarity NPC73505
0.8345 Intermediate Similarity NPC259519
0.8345 Intermediate Similarity NPC165026
0.8345 Intermediate Similarity NPC295719
0.8333 Intermediate Similarity NPC6100
0.8333 Intermediate Similarity NPC206882
0.8333 Intermediate Similarity NPC156888
0.8333 Intermediate Similarity NPC470721
0.8333 Intermediate Similarity NPC266453
0.8333 Intermediate Similarity NPC170485
0.8333 Intermediate Similarity NPC151656
0.8333 Intermediate Similarity NPC200935
0.8333 Intermediate Similarity NPC230919
0.8333 Intermediate Similarity NPC470722
0.8322 Intermediate Similarity NPC174251
0.8322 Intermediate Similarity NPC116019
0.8322 Intermediate Similarity NPC101376
0.8322 Intermediate Similarity NPC153182
0.8321 Intermediate Similarity NPC69029
0.8321 Intermediate Similarity NPC294884
0.8321 Intermediate Similarity NPC158142
0.8321 Intermediate Similarity NPC473413
0.8321 Intermediate Similarity NPC108198
0.8321 Intermediate Similarity NPC10314

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470727 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8417 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.8284 Intermediate Similarity NPD3027 Phase 3
0.8156 Intermediate Similarity NPD6674 Discontinued
0.8148 Intermediate Similarity NPD4625 Phase 3
0.8106 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.8088 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.8045 Intermediate Similarity NPD6696 Suspended
0.8 Intermediate Similarity NPD2861 Phase 2
0.7971 Intermediate Similarity NPD4060 Phase 1
0.7971 Intermediate Similarity NPD1613 Approved
0.7971 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7971 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7971 Intermediate Similarity NPD2238 Phase 2
0.7971 Intermediate Similarity NPD3620 Phase 2
0.797 Intermediate Similarity NPD4749 Approved
0.7956 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7939 Intermediate Similarity NPD4626 Approved
0.781 Intermediate Similarity NPD4908 Phase 1
0.7786 Intermediate Similarity NPD5735 Approved
0.7769 Intermediate Similarity NPD7340 Approved
0.7762 Intermediate Similarity NPD5763 Approved
0.7762 Intermediate Similarity NPD5762 Approved
0.7748 Intermediate Similarity NPD37 Approved
0.7737 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.773 Intermediate Similarity NPD4097 Suspended
0.7727 Intermediate Similarity NPD5691 Approved
0.7721 Intermediate Similarity NPD3094 Phase 2
0.7687 Intermediate Similarity NPD1610 Phase 2
0.7681 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7674 Intermediate Similarity NPD5283 Phase 1
0.7674 Intermediate Similarity NPD1398 Phase 1
0.7647 Intermediate Similarity NPD8651 Approved
0.7597 Intermediate Similarity NPD4967 Phase 2
0.7597 Intermediate Similarity NPD4966 Approved
0.7597 Intermediate Similarity NPD4965 Approved
0.7597 Intermediate Similarity NPD7635 Approved
0.7557 Intermediate Similarity NPD6671 Approved
0.7556 Intermediate Similarity NPD3705 Approved
0.7556 Intermediate Similarity NPD3092 Approved
0.7551 Intermediate Similarity NPD2677 Approved
0.7536 Intermediate Similarity NPD4624 Approved
0.7518 Intermediate Similarity NPD1283 Approved
0.75 Intermediate Similarity NPD2233 Approved
0.75 Intermediate Similarity NPD6234 Discontinued
0.75 Intermediate Similarity NPD4750 Phase 3
0.75 Intermediate Similarity NPD2230 Approved
0.75 Intermediate Similarity NPD2232 Approved
0.7465 Intermediate Similarity NPD4140 Approved
0.7463 Intermediate Similarity NPD1651 Approved
0.7453 Intermediate Similarity NPD5844 Phase 1
0.7448 Intermediate Similarity NPD6099 Approved
0.7448 Intermediate Similarity NPD6100 Approved
0.7447 Intermediate Similarity NPD7985 Registered
0.7445 Intermediate Similarity NPD5327 Phase 3
0.7431 Intermediate Similarity NPD4536 Approved
0.7431 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7431 Intermediate Similarity NPD4538 Approved
0.7426 Intermediate Similarity NPD1091 Approved
0.7426 Intermediate Similarity NPD1611 Approved
0.7424 Intermediate Similarity NPD7157 Approved
0.7422 Intermediate Similarity NPD2684 Approved
0.7413 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD5124 Phase 1
0.7407 Intermediate Similarity NPD5126 Approved
0.7407 Intermediate Similarity NPD5125 Phase 3
0.7388 Intermediate Similarity NPD3091 Approved
0.7388 Intermediate Similarity NPD1548 Phase 1
0.7385 Intermediate Similarity NPD228 Approved
0.7364 Intermediate Similarity NPD3022 Approved
0.7364 Intermediate Similarity NPD3021 Approved
0.7361 Intermediate Similarity NPD6353 Approved
0.7357 Intermediate Similarity NPD3018 Phase 2
0.7355 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7344 Intermediate Similarity NPD290 Approved
0.7343 Intermediate Similarity NPD2979 Phase 3
0.7333 Intermediate Similarity NPD7040 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD7041 Phase 2
0.7329 Intermediate Similarity NPD2438 Suspended
0.7328 Intermediate Similarity NPD7843 Approved
0.7324 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD1281 Approved
0.7292 Intermediate Similarity NPD3657 Discovery
0.7285 Intermediate Similarity NPD2534 Approved
0.7285 Intermediate Similarity NPD2532 Approved
0.7285 Intermediate Similarity NPD2533 Approved
0.7284 Intermediate Similarity NPD7228 Approved
0.7279 Intermediate Similarity NPD3095 Discontinued
0.7279 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD5058 Phase 3
0.726 Intermediate Similarity NPD5588 Approved
0.726 Intermediate Similarity NPD5960 Phase 3
0.7259 Intermediate Similarity NPD7741 Discontinued
0.725 Intermediate Similarity NPD6232 Discontinued
0.7248 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD4628 Phase 3
0.7248 Intermediate Similarity NPD7982 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD3892 Phase 2
0.7244 Intermediate Similarity NPD5929 Approved
0.7237 Intermediate Similarity NPD6090 Discontinued
0.7237 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7237 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7233 Intermediate Similarity NPD4666 Phase 3
0.723 Intermediate Similarity NPD2424 Discontinued
0.7222 Intermediate Similarity NPD7473 Discontinued
0.7211 Intermediate Similarity NPD2935 Discontinued
0.7194 Intermediate Similarity NPD2982 Phase 2
0.7194 Intermediate Similarity NPD1669 Approved
0.7194 Intermediate Similarity NPD2983 Phase 2
0.7188 Intermediate Similarity NPD6959 Discontinued
0.7185 Intermediate Similarity NPD7644 Approved
0.7172 Intermediate Similarity NPD6355 Discontinued
0.7171 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7171 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD5709 Phase 3
0.7162 Intermediate Similarity NPD6005 Phase 3
0.7162 Intermediate Similarity NPD6002 Phase 3
0.7162 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7162 Intermediate Similarity NPD6004 Phase 3
0.7162 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD4380 Phase 2
0.7153 Intermediate Similarity NPD2667 Approved
0.7153 Intermediate Similarity NPD2668 Approved
0.7143 Intermediate Similarity NPD4108 Discontinued
0.7143 Intermediate Similarity NPD4869 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD2675 Approved
0.7124 Intermediate Similarity NPD2676 Approved
0.7123 Intermediate Similarity NPD2157 Approved
0.7122 Intermediate Similarity NPD2981 Phase 2
0.7122 Intermediate Similarity NPD2231 Phase 2
0.7122 Intermediate Similarity NPD2235 Phase 2
0.7114 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD4663 Approved
0.7101 Intermediate Similarity NPD3496 Discontinued
0.7099 Intermediate Similarity NPD2969 Approved
0.7099 Intermediate Similarity NPD2970 Approved
0.7097 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD4005 Discontinued
0.7083 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD7199 Phase 2
0.708 Intermediate Similarity NPD1357 Approved
0.7077 Intermediate Similarity NPD2342 Discontinued
0.7071 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD1934 Approved
0.7067 Intermediate Similarity NPD5177 Phase 3
0.7063 Intermediate Similarity NPD3020 Approved
0.7042 Intermediate Similarity NPD3691 Phase 2
0.7042 Intermediate Similarity NPD3690 Phase 2
0.704 Intermediate Similarity NPD288 Approved
0.7039 Intermediate Similarity NPD6666 Approved
0.7039 Intermediate Similarity NPD6667 Approved
0.7037 Intermediate Similarity NPD3051 Approved
0.7037 Intermediate Similarity NPD3787 Discontinued
0.7037 Intermediate Similarity NPD709 Approved
0.7032 Intermediate Similarity NPD1653 Approved
0.7029 Intermediate Similarity NPD1778 Approved
0.7027 Intermediate Similarity NPD7033 Discontinued
0.7025 Intermediate Similarity NPD7819 Suspended
0.702 Intermediate Similarity NPD7003 Approved
0.7014 Intermediate Similarity NPD7095 Approved
0.7007 Intermediate Similarity NPD6653 Approved
0.7006 Intermediate Similarity NPD7240 Approved
0.7006 Intermediate Similarity NPD6072 Discontinued
0.7 Intermediate Similarity NPD968 Approved
0.6981 Remote Similarity NPD2563 Approved
0.6981 Remote Similarity NPD2560 Approved
0.698 Remote Similarity NPD2531 Phase 2
0.6966 Remote Similarity NPD6812 Clinical (unspecified phase)
0.6966 Remote Similarity NPD5111 Phase 2
0.6966 Remote Similarity NPD5110 Phase 2
0.6966 Remote Similarity NPD6798 Discontinued
0.6966 Remote Similarity NPD5109 Approved
0.6963 Remote Similarity NPD497 Approved
0.696 Remote Similarity NPD844 Approved
0.6959 Remote Similarity NPD7097 Phase 1
0.6959 Remote Similarity NPD7906 Approved
0.6954 Remote Similarity NPD1652 Phase 2
0.6954 Remote Similarity NPD4236 Phase 3
0.6954 Remote Similarity NPD3060 Approved
0.6954 Remote Similarity NPD4237 Approved
0.6953 Remote Similarity NPD940 Approved
0.6953 Remote Similarity NPD846 Approved
0.6951 Remote Similarity NPD2489 Approved
0.6951 Remote Similarity NPD27 Approved
0.6948 Remote Similarity NPD7446 Clinical (unspecified phase)
0.6948 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6948 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6944 Remote Similarity NPD600 Approved
0.6944 Remote Similarity NPD596 Approved
0.6941 Remote Similarity NPD8055 Clinical (unspecified phase)
0.694 Remote Similarity NPD1138 Approved
0.6937 Remote Similarity NPD4581 Clinical (unspecified phase)
0.6937 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6936 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6933 Remote Similarity NPD7266 Discontinued
0.6933 Remote Similarity NPD7229 Phase 3
0.6929 Remote Similarity NPD422 Phase 1
0.6928 Remote Similarity NPD3122 Phase 3
0.6923 Remote Similarity NPD7313 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data